Uvax Bio, LLC
PrivateLast Round
VC Round
Mar 24, 2025
Total Funding Raised
$1.3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Uvax Bio, LLC is a biotechnology company that develops prophylactic vaccines for infectious diseases using its proprietary 1c-SApNP protein nanoparticle platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Uvax Bio, LLC Comparables
Compare Uvax Bio, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| POP Biotechnologies, Inc. | 78% | |
| AstraZeneca | 77% | |
| Novavax Inc. | 74% | |
Uvax Bio, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Mar 24, 2025 | ||||
| Grant | Oct 24, 2022 | ||||
| Series A | Sep 15, 2022 |
Uvax Bio, LLC Investors
Notable investors and investment history
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 102% MoM, reaching 1.9K.
- May 16, 2026
Monthly visitors grew 209% MoM, reaching 498.
Uvax Bio, LLC Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Uvax Bio, LLC's valuation, stock price, and market status.